Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating the safety and efficacy of OROS Oxybutynin Chloride for urge urinary incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• OROS Oxybutynin Chloride (oxybutynin chloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Urinary Incontinence | Phase 3 | Status: COMPLETED